Skip to main content

Language Development

0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Duet Language Intervention ModulesN/A1 trial
Active Trials
NCT04692519Unknown200Est. Jun 2023
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Electrophysiological recordingN/A1 trial
Active Trials
NCT07531706Recruiting50Est. Feb 2028
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Talk STEM Familia appN/A1 trial
Active Trials
NCT03766906Completed50Est. Sep 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Cognition TherapeuticsElectrophysiological recording
Temple TherapeuticsDuet Language Intervention Modules
Oregon TherapeuticsTalk STEM Familia app

Clinical Trials (3)

Total enrollment: 300 patients across 3 trials

NCT07531706Cognition TherapeuticsElectrophysiological recording

Cortical Tracking of Speech in the First Year of Life

Start: Oct 2025Est. completion: Feb 202850 patients
N/ARecruiting
NCT04692519Temple TherapeuticsDuet Language Intervention Modules

Duet 2.0 Starting the Conversation: A New Intervention Model to Stimulate Language Growth in Underserved Populations

Start: Dec 2020Est. completion: Jun 2023200 patients
N/AUnknown
NCT03766906Oregon TherapeuticsTalk STEM Familia app

STEM (Science, Technology, Engineering & Math) Familia Talk

Start: Mar 2019Est. completion: Sep 201950 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 300 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.